Glucotrack, Inc.

Ownership Transactions Reported by 11 Insiders

Symbol
GCTK on Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
Location
301 Rt 17 North, Suite 800, Rutherford, NJ

There are no Buy or Sell transactions made by insiders since 4/23/2024

Glucotrack, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Ballantyne John Director, 10%+ Owner $85.2M Aug 16, 2024
John A. Ballantyne Revocable Living Trust dated 08/01/2017 10%+ Owner $85.1M Jul 30, 2024
Luis Malave Director $4.48M Sep 30, 2021
Drew Sycoff Director, 10%+ Owner $3.72M Jul 1, 2024
Erin Catherine Carter Director $1.42M Dec 31, 2023
Paul Goode Chief Executive Officer $592K Jul 1, 2024
Andrew K. Balo Director $140K Mar 26, 2025
Robert Fischell Director $63.8K Aug 24, 2021
Allen Danzig Director $19K Oct 4, 2022
Peter C. Wulff Chief Financial Officer Jan 28, 2025
James S. Cardwell Chief Financial Officer Oct 11, 2023

Recent Insider Transactions by Companies or Individuals for Glucotrack, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.